Integrated Biopharma Inc Q1 FY2025 Earnings Call

Integrated Biopharma Inc (INBP)

Earnings Call FY2025 Q1 Call date: 2024-11-14 Concluded

Quarter scorecard

Revenue

$13.62M

+5.4% YoY

Diluted EPS

$0.01

Gross margin

10.1%

+3.7 pp YoY

Net income

$259,000

Contract Manufacturing $12.97M

+4.3%

Other Nutraceutical Business $644,000

+34.7%